Harte-Hanks (HHS) Misses Q3 EPS by 72c
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $4.27 --0%
Financial Fact:
Advertising, selling, general and administrative: 11.59M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Advertising, selling, general and administrative: 11.59M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Harte-Hanks (NASDAQ: HHS) reported Q3 EPS of ($0.31), $0.72 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $39.5 million versus the consensus estimate of $51.7 million.
For earnings history and earnings-related data on Harte-Hanks (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- HSBC Raises S&P500 Target to 8,100
- Jefferies Reiterates Buy Rating on Structure Therapeutics (GPCR)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
